Dr. Khalid Wasim Kalim

Cincinnati Childrens Hospital Medical Centre, Cincinnati, Ohio, USA

Email: khalid.kalim@cchmc.org

Qualifications

2012 Ph.D., University of Konstanz, Germany

2006 M.Sc., Jawaharlal Nehru University, New Delhi, India

Publications (Selected)

1. Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, Lauer C, Sylvain C, Ring ER, Shields J, Jiang J, Shwonek P, Parlati F, Demo SD, Bennett MK, Kirk CJ, Groettrup M. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nature Medicine, 2009, Jul 15(7): 781-7.
2. Kalim KW, Michael Basler, Chritopher J Kirk, Marcus Groettrup. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. Journal of Immunology, 2012, Oct 15; 189(8): 4182-93.
3. Kalim KW, Marcus Groettrup. Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit. Molecular Immunology, 2013, Mar 53(3): 274-82.
4. Yang JQ, Kalim KW, Li Y, Zhang S, Hinge A, Filippi MD, Zheng Y, Guo F. RhoA orchestrates glycolysis for T_H2 cell differentiation and allergic airway inflammation. Journal of Allergy and Clinical Immunology, 2015,  Jun 19.